Results: 4

1.
Figure 4

Figure 4. From: Nonreceptor Tyrosine Kinases in Prostate Cancer.

Known Src pathways in prostate cancer. The close proximity of molecules not connected with arrows denote physical association. Red arrows denote activation. Black arrows denote change in levels of molecule. Figure templates were provided by BioCarta (San Diego, CA).

Yu-Ming Chang, et al. Neoplasia. 2007 February;9(2):90-100.
2.
Figure 2

Figure 2. From: Nonreceptor Tyrosine Kinases in Prostate Cancer.

Summary of NRTK mRNA or protein expression in CWR22Rv1, DU145, LNCaP, and PC3 cell lines based on internal data and published reports. NRTK domain drawings and domain information were derived from Simple Modular Architecture Research Tool (SMART, Heidelberg, Germany).

Yu-Ming Chang, et al. Neoplasia. 2007 February;9(2):90-100.
3.
Figure 1

Figure 1. From: Nonreceptor Tyrosine Kinases in Prostate Cancer.

NRTK families and their members in a guide tree. Protein sequences are obtained from Entrez Gene and aligned using Vector NTI Advance software (Invitrogen, Carlsbad, CA). Vector NTI Advance uses the neighbor-joining method of phylogenetic tree construction by Saitou and Nei [127]. The numbers in parentheses after each kinase reflect the calculated distance values between pairs of analyzed sequences.

Yu-Ming Chang, et al. Neoplasia. 2007 February;9(2):90-100.
4.
Figure 3

Figure 3. From: Nonreceptor Tyrosine Kinases in Prostate Cancer.

Western blot analysis of total Src protein expression levels in prostate cancer cell lines. Src is shown as a doublet upon probing in most cell lines. Internal overexpression data (not shown) indicate that both bands are Src and that the doublet is not a result of nonspecific probing of other Src family kinase members.

Yu-Ming Chang, et al. Neoplasia. 2007 February;9(2):90-100.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk